Niki BioSolutions, Inc. (NIKI) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.8x

Market Cap

$5.05M

MomentumView details →

1D Return

−4.76%

YTD Return

−94.04%

RSI (14)

20.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.8x

Market Cap

$5.05M

RSI (14)

20.5

MomentumView details →

1D Return

−4.76%

YTD Return

−94.04%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−9.86%

ROA (TTM)

−12.22%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+75.64%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

0.78x

Quick Ratio

0.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−2.28M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for NIKI.

Similar companies

Klotho Neurosciences, Inc.KLTOW Liminatus Pharma, Inc. Class A Common StockLIMN Pulmatrix, Inc.PULM PharmaCyte Biotech, Inc.PMCB HCW Biologics Inc.HCWB Cardio Diagnostics Holdings, Inc.CDIO Find similar companies →

Latest newsMore news →

No recent news for NIKI.